← Back to catalogue

Cefaly®

FDA UDI

Class II (US FDA UDI)

by Cefaly Technology SPRL

Identity

Trade Name
Cefaly® FDA UDI
Generic Name
Craniofacial analgesia electrical stimulator FDA UDI
Device Name
The Cefaly® Acute device is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older. FDA UDI
Model / Reference
Acute FDA UDI
Description
The Cefaly® Acute device is indicated for the acute treatment of migraine with or without aura in patients 18 years of age or older. FDA UDI

Identifiers

Catalog Number
10405 FDA UDI
Primary DI / UDI-DI
05425018850242 FDA UDI
510(k) Number
K171446 FDA UDI
FDA Product Code
PCC FDA UDI
GMDN Term
Craniofacial analgesia electrical stimulator FDA UDI

Classification

Device Class
Class II FDA UDI
Regulation Number
882.5891 FDA UDI
Commercial Distribution
In Commercial Distribution FDA UDI

Clinical & Handling

Sterile

No

FDA UDI

Single Use

No

FDA UDI

Implantable

No

FDA UDI

Contains Latex

No

FDA UDI

Prescription Use

Yes

FDA UDI

Over-the-Counter

No

FDA UDI

Convenience Kit

Yes

FDA UDI

Combination Product

No

FDA UDI

HCT/P

No

FDA UDI

Premarket Exempt

No

FDA UDI

Lot / Batch Number

No

FDA UDI

Serial Number

Yes

FDA UDI

Expiration Date

Yes

FDA UDI

Manufacturing Date

No

FDA UDI

Category: Craniofacial analgesia electrical stimulator

Cefaly® by Cefaly Technology SPRL — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS

Similar devices

Also classified as Craniofacial analgesia electrical stimulator.

Authorization Coverage (1 country)

Regulatory Authorizations

United States Pending data

FDA UDI

Is this your device? Claim it to add documentation and request validation.

Manufacturer

Sources (1)

  • FDA UDI 9955f733-00c0-4f9a-a646-afc97d5565b5 37 fields · synced Jun 8, 2026